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in a Rhesus sentinel primate in the Zika Forest of Uganda in 1947, to
become a potentially devastating international health threat
nowadays.1
For more than half a century ZIKV virus seemed to pose little
threat to human beings and for that reason, epidemiological,
clinical and therapeutic advances for ZIKV infection have been
slow, as a reﬂection of the relatively small amount of research
carried out on the subject as compared with other mosquito-borne
viral diseases.
Historically restricted to Africa and Asia, outbreaks with
variable impact of autochthonous Zika Fever (ZIKF) were reported
in the Paciﬁc region since 2007 and then, as predicted from the
distribution of the vectors Aedes aegypti and Aedes albopictus, ZIKV
began to infect patients in South America in 2014, and eventually
spread to Central and North America.2 The ﬁrst molecularly
conﬁrmed case of Zika virus infection in the Americas Region was
reported from Brazil in March 2015.3
In contrast to the relatively slow spread of Ebola virus through
West Africa, the ZIKF epidemics in the Paciﬁc and Americas regions
moved very rapidly. Indeed, based on the severity of the health
threat associated with the continuing spread of ZIKV disease in
Latin America and the Caribbean, on 1 February 2016, the World
Health Organization declared Zika virus-associated clusters of
microcephaly and related neurological disorders a ‘Public Health
Emergency of International Concern’.4
The number of patients affected by ZIKF in the Western
Hemisphere increased sharply. As of August 22, 2016 45 countries
and Territories throughout the Americas have reported more than
577,000 locally-acquired cases, with estimates of several million
real cases, over a period of about one year and a half.5
Mathematical models have estimated the basic reproduction
number (R0), or number of cases one case generates on average
over the course of its infectious period in an otherwise uninfected
population, for ZIKV in the region from 1.4 to 6.6 as key measure of
transmissibility in a number of settings.6
The underlying reasons for the observed global spread of ZIKV
are not fully understood highlighting how little we still understand
about the global spread of ﬂaviviruses and other vector-borne
diseases. Hypotheses currently under consideration include
possibilities as diverse as adaptive evolution of ZIKV allowing
for an enhanced infectivity to urban Aedes species vectors, or
alternatively, adaptive evolution in the human host, leading to
higher levels of viremia which would instead enhance both the
transmission by the biting mosquitos and the risk of transplacental
fetal transmission. Not least important appears to be thehttp://dx.doi.org/10.1016/j.ijid.2016.09.001
1201-9712/ 2016 Published by Elsevier Ltd on behalf of International Society for Infect
creativecommons.org/licenses/by-nc-nd/4.0/).introduction of ZIKV into naive populations of new areas fueled
by increased global travel, expansion of tropical urban centers, and
abundant susceptible mosquito populations.
The Western hemisphere has faced an unprecedented epide-
miological situation with the widespread cocirculation of Dengue
(DENV), Chikungunya (CHIKV) and Zika (ZIKV), three arboviruses
of major public health importance. The simultaneous emergence
and reemergence of this three agents present new challenges to
both clinicians and public health authorities.7
Overlapping clinical features between diseases caused by ZIKV,
DENV and CHIKV, as well as the possible cross-reactivity between
DENV and ZIKV and other ﬂaviviruses when immunological
methods are used for IgM detection, hamper the reliable diagnosis
of the illness in areas with active circulation of both viruses.8
Compounding this situation even further is the possibility of
coinfections with any combination of them in the human host.8,9,13
To the present, experimental dual infection in mosquitos has only
been established with Chikungunya and Dengue.10
With the high possibility of IgM and IgG cross-reactivity in
immunoassays, particularly between DENV and ZIKV, differential
diagnosis via detection of viral RNA is critical for identifying the
causative agent of these infections in The Americas’ context.11 The
latter is clearly exempliﬁed by the report from Villamil-Go´mez
et al.12 in the current issue describing a pregnant Colombian
woman with triple coinfection (ZIKV-DENV-CHIKV). A recent
publication from several of the coauthors has already shown that
coinfection in some endemic areas may be as high, or even higher
than monoinfections.13 However, the use of diagnostic technolo-
gies more affordable to developing countries, such as nested PCR,
may pose a higher risk of false positive results as compared to real-
time PCR; therefore, some results would require conﬁrmation by
other validated techniques like RT-PCR, and/or viral sequencing, as
performed in the case published herein.12 Simultaneous qualita-
tive detection and differentiation of RNA from ZIKV, dengue virus,
and chikungunya virus in human sera or cerebrospinal ﬂuid, and
qualitative detection of ZIKV virus RNA in urine and amniotic ﬂuid
(each collected alongside a patient-matched serum specimen) can
be accomplished by the CDC Trioplex rRT-PCR assay recently
approved by the USA Food and Drug Administration agency.14
An interesting particularity of ZIKV is its capacity to be sexually
transmitted in addition to the possibility of perinatal and
transplacental transmission during childbirth and possibly, by
blood transfusion.15,16 Evidence of sexual transmission was ﬁrst
suggested in 201117 and later conﬁrmed by several reports18,19
Although in only few instances the patients involved experienced
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by Huits RMHG, et al.22 conﬁrm and indicate that microhematos-
permia may be a relatively common event. In fact, of four patients
convalescent of recent ZIKV infection followed prospectively to
assess the kinetic of the virus in semen, one experienced
asymptomatic patent hematospermia, and three others micro-
hematospermia, suggesting that men with acute infection may
develop inﬂammatory changes in the urogenital tract that would
play a potential role in the shedding and persistence of the virus in
this body compartment with viral loads higher than concurrent
sera levels.22 No other arbovirus has shown any association with
hematospermia or is found in the semen. Moreover, the
demonstration of infectious ZIKV in urine, along with the detection
of ZIKV RNA in urine even after viremia has cleared, could be
consistent with ZIKV replication in urogenital tissues.17,23,24 Of
note, at least two instances of sexual transmission from a ZIKV
carrier who never showed symptoms has been reported.25,26
Although mosquito bite represents unquestionably the main
mode of transmission of Zika, the low viremia observed in many
patients and the rapid spread within and among countries in some
regions like the Americas supports a role for other modes of
transmission, such as sexual intercourse, that could contribute to
its rapid spread.27 As identifying and characterizing cases of
sexually transmitted Zika virus infection in areas experiencing
intense autochthonous vector-borne Zika virus transmission is a
difﬁcult task, most reports of sexual transmission originate in areas
where autochthonous transmission is not occurring which allows
for unique and important opportunities to learn about this
emerging mode of transmission.
The immune-privileged nature of the testes may allow ZIKV to
persist in this tissue for prolonged periods, serving as reservoirs
with the potential to initiate new transmission cycles from
otherwise healthy individuals. Seminal shedding of ZIKV seems
to coincide with the duration of spermatogenesis (69–80 days),
suggesting the possibility of infection of sperm progenitors and
viral shedding during the differentiation process.22 Of note,
immunedeﬁcient mice with experimental ZIKV infection show
the highest levels of viral replication in the testes and brain.28
However, further studies aimed to understand persistence of ZIKV
in semen and the real risk of ZIKV sexual transmission are
necessary.
The European Center for Diseases Control currently recom-
mends deferral of semen donation for 28 days after returning from
areas where ZIKV is endemic.29 Of note, in one recently published
case ZIKV RNA was detected in semen up to 134 days indicating a
prolonged potential risk for sexual transmission, for a period
longer than previously reported.30 These latest ﬁndings may
suggest a revision of the recommendations of prevention of sexual
transmission and infection in pregnancy issued by current health
authorities. Indeed, very recently WHO ofﬁcially advised that all
men and women returning from areas where transmission of Zika
virus is known to occur should adopt safer sex practices or consider
abstinence for at least 6 months upon return to prevent Zika virus
infection through sexual transmission.31 By comparison, suspected
sexual transmission of Ebola virus has occurred 179 days after
onset of the disease and Ebola virus RNA has been detected in
semen for 4–6 months after disease onset in more than 40% of
survivors.32,33
Little information is available on the cellular tropism of ZIKV
and the nature of the cellular receptors that mediate its entry in
different tissues, as well as the mechanisms of ZIKV infection and
the signaling pathways and antiviral immune response of the host
elicited by this virus. In this respect, the work by Chen J, et al.
revealing that uterine ﬁbroblasts (UF) are susceptible to infection
opens the possibility of a relevant role for the uterus as a conduit
for virus during heterosexual intercourse.34These results are in accordance with earlier and recent reports
in the literature underscoring the importance of ﬁbroblasts as a
primary cell type of replication for ﬂaviviruses, in close association
with host cell membranes, that may contribute to subsequent viral
dissemination.35,36 The primary infection of skin ﬁbroblasts with
ZIKV is linked to the up-regulation with TLR3 mRNA expression
and increased transcription of RIG-I and MDA5, all of which are
related to innate immune responses to RNA virus infections. This is
followed by an increase in the expression of interferon-alpha and -
beta, and their downstream pathways of immune activation.36
Additional investigations are needed to deﬁne the exact contribu-
tion of speciﬁc ﬁbroblasts cell receptors and/or attachment factors
to ZIKV infection, tropism and pathogenesis.
Another paper included in this issue by Coelho F, et al.,37 from
Rio de Janeiro, Brazil, indicates that, in some contexts, women of
reproductive age groups are far more likely to get Zika than men;
suggesting the possibility that men-to-women sexual transmis-
sion may account for this difference. A caveat to this conclusion is
the fact that just because the statistical data shows an apparent
correlation between these two parameters it doesn’t mean that
there is necessarily an underlying causal relationship; besides,
female to male sexually transmitted Zika virus has been also
described recently. Indeed, the conﬁrmation of at least one case of
ZIKV infection transmitted from a symptomatically infected
woman to a male sex partner,38 and the detection of ZIKV RNA
in vaginal ﬂuids of a patient 3 days after symptom onset and in
cervical mucus up to 11 days,39 indicates that partners of infected
women, might acquire ZIKV through exposure to vaginal
secretions or menstrual blood during sexual intercourse. There-
fore, other factors would explain in part why women in the
sexually active age bracket may be more affected.
As illustrated by the paper of Machado-Alba JE, et al. also found
in this issue,40 Guillain Barre Syndrome (GBS) appears to be a
genuine risk in patients recently infected with ZIKV. This
association was ﬁrst reported during the outbreak of ZIKF in
French Polynesia between 2013 and 2014 (risk: 24 per 100,000
ZIKV infections).41 The risk of GBS reported was 10 times the
annual risk in the USA (1.8 per 100,000). Most cases occurred in
symptomatic patients with a median of 6 days of symptoms in 88%
of the patients.41
According to PAHO, an apparent increased incidence of GBS has
also been observed in Brazil, Colombia, and El Salvador in
association with the current epidemic of ZIKF in the Americas.5
To date, such a rise in the incidence of GBS cases has been reported
in at least 12 countries and territories with laboratory conﬁrmed
cases of ZIKV.5 Mortality of ZIKV and GBS is expected to be higher
in medical environments where respiratory support is not
available or scarce, as is the case in many locations of Latin
America. It should be noted that changes in the incidence of GBS in
the region may not be related exclusively to ZIKV, but also to
ﬂuctuations in the incidence of DENV and CHIK, or other viral and
bacterial pathogens.
Finally, the work by Rodriguez-Morales A, et al.42 published
herein represents one of the ﬁrst to use of Geographic Information
Systems (GIS)-based epidemiological maps in a Zika epidemic. The
incorporation of these technologies would allow to integrate
preventive and control strategies, as well as public health policies,
for joint control of this and similar vector-borne diseases in any
area of a country. As dengue, CHIKV and ZIKV widely cocirculate in
the continent nowadays; updated GIS maps of these infections as
well as coinfections will be potentially useful.
GIS-based technologies drawing on local census data may
generate useful information showing public health experts where
to target prevention efforts, particularly among women of child-
bearing age and their partners. By allowing to monitor the spread
of the ZIKV, they can properly dole out domestic assistance and
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maps may also provide relevant information aimed to assess the
risk of travelers to speciﬁc destinations in highly transmission
areas allowing detailed prevention advices.
As health specialists need reliable information to make sound
decisions about what preventive actions to take, the use of GIS
collected information to locate the most vulnerable populations in
a given region represents an important stride than can help in
educating people on the risks of the ZIKV and bring actions that can
protect health and curb the spread of disease.
Undoubtedly, protection of exposure of susceptible individuals
to ZIKV and suitable vector control actions are the only tools
available to reduce the advance and impact of this infection at the
present moment, especially until effective vaccines and antiviral
therapy become available.
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